Diet-Induced-Obesity Resistant Phenotypes in Humans
2 other identifiers
observational
9
1 country
1
Brief Summary
Background: \- Obesity is the result of many factors, including genetics and lifestyle, such as over-eating high-calorie foods and not being physically active. Obesity affects approximately one third of adults in the United States. Researchers often study individuals who are already overweight and obese, but another approach is to examine people who stay thin despite eating whatever they want and not exercising. Studying these thin individuals will enhance understanding of why some people become obese and others do not, which may lead to novel treatments for obesity. Objective: \- To study the metabolism, body composition, body temperature, physical activity, and blood chemistries of healthy lean adults before and after adding 1,000 extra Calories per day to their normal diet. Eligibility: \- Healthy adults, 30 to 50 years of age, who have never been overweight after adolescence, who are currently weight-stable, sedentary, and eating without restrictions. Design: \- The entire study will take about 9 weeks and will include the following outpatient and inpatient visits: \<TAB\>- Outpatient screening visit and monitoring: Physical examination and blood test at screening; then, one week of physical activity monitoring (e.g., with a pedometer-like device called an accelerometer) and completing a food diary. \<TAB\>- Baseline inpatient visit (5 days): Volunteers will eat a normal diet to maintain body weight. Energy expenditure, body composition, physical fitness, activity level, and eating behavior will be measured. Urine and blood samples will be taken. Volunteers may go home for the weekend or stay at the metabolic clinical research unit (MCRU). \<TAB\>- Inpatient feeding week 1 (5 days): Volunteers will eat a normal diet plus milkshakes for added calories. All the same measurements during the baseline week visit will be repeated. \<TAB\>- Outpatient feeding weeks 2 3: Volunteers will eat breakfast at the MCRU everyday for the next 2 weeks and take prepared meals home with them (volunteers may also stay at the MCRU for the 2 weeks if they prefer). Volunteers will drink a non-radioactive (heavy) water called doubly labeled water to measure energy expenditure in their normal living environment Daily urine samples will be collected. \<TAB\>- Inpatient feeding week 4 (5 days): Volunteers will continue eating a normal diet plus milkshakes for added calories. This stay and measurement is identical to inpatient feeding week 1. \- Volunteers will be contacted at 6 and 12 months to assess any changes in body weight, diet, and physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2009
CompletedFirst Submitted
Initial submission to the registry
October 20, 2009
CompletedFirst Posted
Study publicly available on registry
October 21, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 22, 2012
CompletedDecember 3, 2019
October 22, 2012
October 20, 2009
November 30, 2019
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Healthy normal men and women between 25-50 years of age;
- BMI between 18.5 and 25.0 kg/M(2);
- Self-reported as having had trouble gaining weight, who doing little or no exercise, self-described or by friends or family members as an overeater, and who have never tried to lose weight.
You may not qualify if:
- A self-reported history of overweight after the age of 18, other than during pregnancy for women;
- Recent weight changes \>2% of current body weight in the last 6 months;
- Current or past history of eating disorders such as binge eating, anorexia nervosa, or bulimia, by psychological evaluations;
- Current or past history of intentional weight loss by self-report, other than postpartum weight loss;
- High physically demanding occupations or volitional exercise \>20 total minutes/day of moderate intensity or higher (as measured by sweating), \>2 days/week, by self-report;
- Significant dietary limitations (multiple food allergies/intolerances, vegan diet, etc.) that may affect absorption and body weight, or special dietary requirements that are difficult to accommodate with by study diets;
- Significant physical limitations that may preclude completing the majority of the tests in this study;
- Current pregnancy, recent pregnancy (\<3 years), current/recent breast feeding (\<1 year), or perimenopausal status. During the study, women may be asked to use birth control and will undergo repeated pregnancy testing. Subjects who refuse these tests will be excluded;
- Current or past medical conditions that are known to affect energy metabolism and body weight regulations, including HIV/AIDS, cancer, cardiac ischemia, dyslipidemia, thyroid and parathyroid disorders, hypo- or hypertension, diabetes (type 1 or type 2) or impaired glucose tolerance, congenital or acquired lipodystrophy, hepatic, renal, neuromuscular, celiac disease and other malabsorptive conditions, known genetic disorders that alter lipid metabolism, or cardiac failure as assessed by history and physical exam;
- Any psychiatric condition (including psychosis) or personality disorder as judged by the PI or Co-PI that would impede participation in the study;
- Smoking (currently or within the past year), excessive caffeine (\>500 mg/day) and/or alcohol intake (\>2 drinks/day for men, \> 1 drink/day for women), as assessed by self reports and serum thiocyanate;
- Taking narcotics, cocaine, or marijuana which would alter metabolism (positive urine toxicology screen)
- Any use of medications or nutritional supplements known to increase EE, depress food intake, or affect absorption;
- Unwilling or unable to give informed consent;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 Apr 5;295(13):1549-55. doi: 10.1001/jama.295.13.1549.
PMID: 16595758BACKGROUNDComuzzie AG, Allison DB. The search for human obesity genes. Science. 1998 May 29;280(5368):1374-7. doi: 10.1126/science.280.5368.1374.
PMID: 9603720BACKGROUNDColeman DL. Obesity genes: beneficial effects in heterozygous mice. Science. 1979 Feb 16;203(4381):663-5. doi: 10.1126/science.760211.
PMID: 760211BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kong Y Chen, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 20, 2009
First Posted
October 21, 2009
Study Start
September 19, 2009
Study Completion
October 22, 2012
Last Updated
December 3, 2019
Record last verified: 2012-10-22